Clinical Trial Update: Anakinra for Behcet s Disease [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial of anakinra for Behçet's disease has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease

Drugs mentioned

• Anakinra (Kineret) (Anakinra)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Autoimmune Connective Tissue Disorder, Immune System Diseases | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-05-12